Compare CVS Health Corp (CVS) vs Materials Select Sector SPDR Fund (XLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Materials Select Sector SPDR Fund — how do they compare? CVS Health Corp trades at $93.68 (market cap $122.36B), while Materials Select Sector SPDR Fund trades at $53.25. The key difference: CVS Health Corp pays a 2.78% dividend while Materials Select Sector SPDR Fund pays none, and Materials Select Sector SPDR Fund is trading nearer its 52-week high, CVS Health Corp nearer its low. Which is the better fit depends on your goals.
| CVS | XLB | |
|---|---|---|
Market Cap | $122.36B | — |
Sector | Health | — |
52-Week High | $110.60 | $53.62 |
52-Week Low | $65.51 | $42.23 |
Enterprise Value | $184.71B | — |
Dividend Yield | 2.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
XLB trades at $52.86, up 1.32% today, with a bullish technical signal from moving averages and neutral oscillators. The materials sector benefits from AI infrastructure demand and strong Q2 earnings momentum, as noted by Zacks Investment Research on August 6, 2026. A dividend of $0.19 is scheduled for June 2026, while recent news highlights sector resilience amid geopolitical shifts.
Outlook is positive due to cyclical recovery and AI-driven demand, but risks include pricing pressures and economic sensitivity. Analysts see limited near-term upside after recent gains, with a hold rating common. Institutional interest remains strong, supporting stability amid volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Materials Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: chemicals; metals and mining; paper and forest products; containers and packaging; and construction materials. The fund is non-diversified.
Read more on XLB →
